Edmond de Rothschild Holding’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-168
Closed -$117K 646
2020
Q3
$117K Sell
168
-38
-18% -$29.6K ﹤0.01% 450
2020
Q2
$163K Buy
206
+16
+8% +$12.1K 0.01% 395
2020
Q1
$113K Sell
190
-7
-4% -$6.82K 0.01% 382
2019
Q4
$224K Sell
197
-154
-44% -$167K 0.01% 367
2019
Q3
$418K Buy
351
+4
+1% +$6.11K 0.02% 319
2019
Q2
$572K Buy
347
+78
+29% +$135K 0.02% 284
2019
Q1
$548K Buy
+269
New +$474K 0.02% 282

Other funds holding BLUE

Edmond de Rothschild Holding's BLUE Position: Q4 2020 in Review

Edmond de Rothschild Holding sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 168 shares — an estimated $117K sold.

Edmond de Rothschild Holding first reported a position in BLUE in Q1 2019 and held it in 7 quarters. The position peaked at $572K in Q2 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.

  • Edmond de Rothschild Holding reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 168 bluebird bio shares in Q4 2020, an estimated $117K.
  • Edmond de Rothschild Holding first reported a position in bluebird bio in Q1 2019 and held it in 7 quarters.
  • Edmond de Rothschild Holding's bluebird bio position peaked at $572K in Q2 2019.
  • 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2020, filed 12 Feb 2021.